share_log

京新药业(002020.SZ):山东京新的1.1期项目已经开始试生产

Zhejiang Jingxin Pharmaceutical (002020.SZ): Shandong Jingxin's Phase 1 project has started trial production.

Gelonghui Finance ·  Jul 30 03:40

Zhejiang Jingxin Pharmaceutical (002020.SZ) stated on the investor interaction platform on July 30th that Shandong Jingxin's Phase 1 project has begun trial production. The purpose of the project implementation is to further improve the company's active pharmaceutical ingredient industry chain and contribute to the cost reduction and efficiency improvement of existing active pharmaceutical ingredient production. The short-term products will mainly supply Shaoxing Jingxin, and the export proportion will gradually increase in the future according to the market situation.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment